These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1297605)

  • 41. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition?
    Moro E; Alessandrini P; Zambon C; Pianetti S; Pais M; Cazzolato G; Bon GB
    Diabet Med; 1999 Aug; 16(8):663-9. PubMed ID: 10477211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefits of micronised Fenofibrate in type 2 diabetes mellitus subjects with good glycemic control.
    Tan CE; Chew LS; Tai ES; Chio LF; Lim HS; Loh LM; Shepherd J
    Atherosclerosis; 2001 Feb; 154(2):469-74. PubMed ID: 11166781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria.
    Dullaart RP; Dikkeschei LD; Doorenbos H
    Diabetologia; 1989 Sep; 32(9):685-9. PubMed ID: 2507381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.
    Bays HE; McKenney JM; Dujovne CA; Schrott HG; Zema MJ; Nyberg J; MacDougall DE;
    Am J Cardiol; 2003 Sep; 92(5):538-43. PubMed ID: 12943873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.
    Hernández-Mijares A; Lluch I; Vizcarra E; Martínez-Triguero ML; Ascaso JF; Carmena R
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):1-6. PubMed ID: 10812581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypobetalipoproteinemia associated with apo B-48.4, a truncated protein only 14 amino acids longer than apo B-48.
    Ruotolo G; Zanelli T; Tettamanti C; Ragogna F; Parlavecchia M; Viganò F; Catapano AL
    Atherosclerosis; 1998 Mar; 137(1):125-31. PubMed ID: 9568744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double blind study of the effect of acipimox on serum lipids, blood glucose control and insulin action in non-obese patients with type 2 diabetes mellitus.
    Fulcher GR; Catalano C; Walker M; Farrer M; Thow J; Whately-Smith CR; Alberti KG
    Diabet Med; 1992 Dec; 9(10):908-14. PubMed ID: 1478035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patients.
    Wägner AM; Pérez A; Zapico E; Ordóñez-Llanos J
    Diabetes Care; 2003 Jul; 26(7):2048-51. PubMed ID: 12832311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets.
    Kappelle PJ; Dallinga-Thie GM; Dullaart RP;
    Biochim Biophys Acta; 2010 Jan; 1801(1):89-94. PubMed ID: 19800983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus.
    Gallou G; Ruelland A; Campion L; Maugendre D; Le Moullec N; Legras B; Allannic H; Cloarec L
    Diabete Metab; 1994; 20(3):258-64. PubMed ID: 8001713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.
    Tan CE; Chew LS; Chio LF; Tai ES; Lim HS; Lim SC; Jayakumar L; Eng HK; Packard CJ
    Diabetes Res Clin Pract; 2001 Feb; 51(2):107-14. PubMed ID: 11165690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction.
    Kongsayreepong R; Chutivongse S; George P; Joyce S; McCone JM; Garza-Flores J; Valles de Bourges V; de La Cruz DL; Perez-Palacios G; Rosseneu M
    Contraception; 1993 Feb; 47(2):177-91. PubMed ID: 8449018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Relation of plasma glucose levels to serum lipids and apolipoproteins levels in middle and old age males].
    Duan Y; Wu Z; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):382-4. PubMed ID: 12536570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
    Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The apolipoprotein B/apolipoprotein A-I ratio in healthy men with normolipidemia: limits of variation and relationship with other lipid parameters.
    Kaneva AM; Potolitsyna NN; Bojko ER
    Clin Chem Lab Med; 2014 Dec; 52(12):e291-3. PubMed ID: 24940716
    [No Abstract]   [Full Text] [Related]  

  • 57. Can the hypotriglyceridemic effect of fish oil concentrate be sustained?
    Schectman G; Kaul S; Cherayil GD; Lee M; Kissebah A
    Ann Intern Med; 1989 Mar; 110(5):346-52. PubMed ID: 2492785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus.
    Császár A; Dieplinger H; Sandholzer C; Karádi I; Juhász E; Drexel H; Halmos T; Romics L; Patsch JR; Utermann G
    Diabetologia; 1993 Jan; 36(1):47-51. PubMed ID: 8436252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Nutrition and plasma apoproteins B and A-I].
    Khaltaev NG; Perova NV; Dobordzhginidze LM; Metel'skaia VA; Grishenkov EA
    Ter Arkh; 1987; 59(5):108-12. PubMed ID: 3112987
    [No Abstract]   [Full Text] [Related]  

  • 60. Association of coronary heart disease with serum lipid and apolipoprotein concentrations in long-term diabetes. Results of the Erfurt study.
    Schauer UJ; Pissarek D; Panzram G
    Acta Diabetol Lat; 1989; 26(1):35-42. PubMed ID: 2501960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.